GALECTIN THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Galectin Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $737K, a 42.8% increase year-over-year.
  • Galectin Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.42M, a 4.57% decline year-over-year.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.26M, a 21.1% decline from 2022.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.87M, a 38.1% increase from 2021.
  • Galectin Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $2.08M, a 15.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.26M -$606K -21.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.87M +$791K +38.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $2.08M +$277K +15.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.8M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.